Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score-Matched Analysis from the Korean College of Rheumatology Biologics Registry.
Wook-Young BaekEunyoung LeeSun-Kyung LeeYong-Beom ParkTae-Jong KimPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
ClinicalTrials.gov identifier: NCT01965132.